Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Agreement Overview and Key Terms
TECH logo

Bio-Techne to be Acquired by Merck KGaA for $73.00 Per Share

TECH8-KFiling Date: 6/26/2026
Bio-Techne Corporation
Description

What this story covers

Bio-Techne Corporation will become a wholly-owned subsidiary of Merck KGaA, Darmstadt, Germany, in an all-cash deal at $73.00 per share. The merger combines Bio-Techne's specialized protein analysis tools with Merck's global commercial scale and infrastructure.

Story snapshot

CompanyBio-Techne Corporation
TickerTECH
VariantStandard detailed
Duration4:03
Filing type8-K
PeriodQ4 2026
IndustryHealthcare & Pharmaceuticals
Accession0001999371-26-013527
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing8-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in